The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (6 analysts) rates it hold, with a mean price target of $37.
Hess Midstream LP
HESM · the NYSE · USD · Market cap $8.2B
Hess Midstream LP acquires, owns, operates, and develops midstream assets and provide fee-based services to sponsor, its subsidiaries, and third-party customers in the United States.
FAIL · Does not pass the screenAt the last full screen
2026-09-11
Screened 2026-09-11 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
Hess Midstream LP holds its Accumulation at $39.97. The statistical read favours the buyers, held for 152 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the buyers, held for 152 days |
| Price at the screen | $39.97 |
| Valuation | 13.78 trailing · 12.92 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.50 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 85.96% | Below 33% | Interest-bearing debt is 86.0% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 3.47% | Below 49% | Money owed to the company is 3.5% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. The price runs 20.6% above the base estimate.
Third-party analyst targets: 6 covering, consensus None. The average target sits −5% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsOil pipes promise steady fees yet trap value
Picture the steady flow of crude from wellhead to export terminal. Hess Midstream collects fees for moving and storing that oil, yet the business sits inside an industry where volumes and prices swing with global demand. Revenue growth sits at just 2 percent and the shares trade above our fair value, leaving no margin of safety at the current price.
The forward multiple of 13.3 times earnings looks modest next to a 23 percent profit margin and 153 percent return on equity. Those figures reflect the fee-based model and high leverage, but they also sit at a point in the cycle where earnings may already be near peak. Analyst consensus calls the stock underperform with a median target below the current quote, and growth remains modest.
The real risk is the classic cyclical trap. A low multiple on elevated earnings can signal the top of the cycle rather than a bargain, and any drop in drilling activity would quickly cut volumes. Currency and commodity exposure add further volatility even though the ethical screen is clear. Analysis, not advice.
| Forward P/E | 12.9xreasonably valued |
| Trailing P/E | 13.8xreasonably valued |
| EPS, trailing | 2.90 |
| EPS, forward | 3.09 |
| Revenue growth | -3.7%revenue is shrinking |
| Profit margin | 23.2%healthy profit margins |
| Return on equity | 150.7%an exceptional return on shareholder capital |
| FCF yield | 6.06% |
| Dividend yield | 789.00% |
| Debt to equity | 9.48heavy leverage: higher risk if revenue softens |
| Current ratio | 0.77below 1: short-term bills exceed liquid assets |
| Beta | 0.50barely tracks the market's swings |
| Short interest, float | 0.07% |
| 52-week range | 31.63 - 41.44 |
| Market cap | $8.2B |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeHESM trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (6 analysts) rates it hold, with a mean price target of $37.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 10%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (6 analysts) rates it hold, with a mean price target of $37.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $39.19 | +0.1% | · | $1,001 | +0.1% |
| 2 months | $38.76 | +1.2% | $0.78 | $1,032 | +3.2% |
| 3 months | $38.13 | +2.8% | $0.78 | $1,049 | +4.9% |
| 6 months | $33.03 | +18.7% | $1.54 | $1,234 | +23.4% |
| 1 year | $35.73 | +9.7% | $3.04 | $1,182 | +18.2% |
| 2 years | $29.93 | +31.0% | $5.80 | $1,504 | +50.4% |
| 3 years | $22.76 | +72.2% | $8.30 | $2,087 | +108.7% |
| 5 years | $17.65 | +122.1% | $12.66 | $2,938 | +193.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever HESM does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.